4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000899243-21-000136
CEO sold 22,300 shares at an average $84.94 ($1,894,125)
From the SEC's structured data for this filing
Trades in this filing
Evans John M. · CEO
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-30 | Sale : show line 1 in the form | −1,366 | $81.14 | $110,837 | 991,891 | D |
| 2020-12-30 | Sale : show line 2 in the form | −4,100 | $82.33 | $337,553 | 987,791 | D |
| 2020-12-30 | Sale : show line 3 in the form | −4,925 | $83.76 | $412,518 | 982,866 | D |
| 2020-12-30 | Sale : show line 4 in the form | −1,422 | $85.35 | $121,368 | 981,444 | D |
| 2020-12-30 | Sale : show line 5 in the form | −7,196 | $86.21 | $620,367 | 974,248 | D |
| 2020-12-30 | Sale : show line 6 in the form | −504 | $86.79 | $43,742 | 973,744 | D |
| 2020-12-30 | Sale : show line 7 in the form | −1,121 | $88.12 | $98,783 | 972,623 | D |
| 2020-12-30 | Sale : show line 8 in the form | −1,666 | $89.41 | $148,957 | 970,957 | D |
| Open-market sales · 22,300 sh · avg $84.94 · $1,894,125 | ||||||
Loading xslF345X03/doc4.xml…